COMPARATIVE STUDY ON USE OF PLATELET-RICH PLASMA ALONE AND IN COMBINATION WITH ALPHA-TRICALCIUM PHOSPHATE CEMENT FOR BONE REPAIR IN RATS  by Sebben, Alessandra Deise et al.
17 artigo 511
ORIgINAL ARtICLE
1 – MSc in Health Sciences. Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
2 – PhD in Nuclear Biosciences and Medical Physics. Professor at the Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
3 – BSc in Biomedicine, Feevale University, Novo Hamburgo, RS, Brazil.
4 – MD. Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.
5 – Professor, Coordinator of the Biomaterials Laboratory and Head of the Department of Materials Engineering, Federal University of Rio Grande do Sul (UFRGS), Porto 
Alegre, RS, Brazil. 
6 – Full Professor, Unifesp; Professor in the Department of Surgery, FAMED, Pontifical Catholic University of  Rio Grande do Sul (PUCRS); Heads of the Hand and Recons-
tructive Microsurgery Clinic, Hospital São Lucas, PUCRS, Porto Alegre, RS, Brazil.
Work performed in the Medical Skills and Surgical Research Laboratory, PUCRS, and in the Biomaterials Laboratory, UFRGS.
Correspondence: Av. Ipiranga 6690, prédio 64, Partenon, 90610-000 Porto Alegre, RS, Brazil. E-mail: adsebben@gmail.com 
Work received for publication: May 25, 2011; accepted for publication: July 31, 2011.
COmPARATIVE STuDY ON uSE OF PLATELET-RICH PLASmA ALONE 
AND IN COmBINATION WITH ALPHA-TRICALCIum PHOSPHATE 
CEmENT FOR BONE REPAIR IN RATS 
Alessandra Deise Sebben1, Gabriela Hoff2, Caroline Peres Klein3, Thiago Alexi de Freitas4, Camilla Assad4,                                      
Luís Alberto dos Santos5, Jefferson Braga Silva6
ABstRACt
Objectives: To evaluate the effect of alpha-tricalcium phosphate 
(α-TCP) cement combined with platelet-rich plasma (PRP) on 
osteogenesis, and to compare the results with use of PRP alone. 
Methods: A bilateral defect was produced in rat femurs and was 
filled with one of two types of treatments (PRP or α-TCP + 
PRP). The outcomes were evaluated after four and eight weeks. 
Radiographic images provided values for the lesion area, and 
histology (picrosirius staining) indicated the area of new bone 
formation. Results: The means relating to the lesion area of the 
α-TCP + PRP group (2.64 ± 2.07 and 1.91 ± 0.93 mm², after 
four and eight weeks, respectively) showed numerically better 
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but non-significant results (p > 0.05) than those seen in the PRP 
group (5.59 mm ² ± 2.69 and 3.23 ± 1.46 mm ², after four and 
eight weeks, respectively). The mean new bone formation rates 
were 62.7% ± 12.1 and 79.01% ± 6.25 in the PRP group, and 
73.3% ± 12.7 and 85.86% ± 10.45 in α-TCP + PRP group, after 
four and eight weeks, respectively (p > 0.05). Conclusion: The 
data from this study suggest that treatment with α-TCP cement 
combined with PRP does not show any significant difference 
in comparison with PRP alone. However, there is a possible 
early effect on bone regeneration when the two biomaterials 
are applied together. 
Keywords – Animals; Bone Substitutes; Growth Factor
INtRODUCtION
Musculoskeletal injuries are considered to be 
one of the main causes of severe pain and morbidity 
worldwide. This damage often causes physical inca-
pacitation and substantially diminishes the quality of 
life of individuals affected by such injuries(1,2). Sports 
activities and traffic accidents are the main agents 
of these injuries, which have a large socioeconomic 
impact and have high financial costs(2).
Reconstruction of large bone segments consequent 
to pathological events such as trauma, inflammation 
and surgical treatment of tumors continues to be 
an important clinical problem. Injured bone tissue 
has the capacity to return to its original structure(3), 
but if the defect consists of loss of bone mass, the 
regeneration becomes limited. Among the therapeutic 
alternatives most used for reconstructing large bone 
lesions are transplantation of bone grafts (autologous, 
homologous or heterologous) and implantation of 
different biomaterials(4).
Autologous grafts are characterized as having high 
osteoinductive capacity, but they present disadvantages 
such as the need for a second surgical intervention to 
remove the graft, the possibility of morbidity at the 
site and a scarcity of donor tissue(5). With the aim 
of assisting in accelerating the modulation of repairs 
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to injured bone, and to overcome the disadvantages 
of autologous grafts, inorganic bone substitutes have 
been widely applied as biomaterials in orthopedics 
and dentistry(6). Among these inorganic materials, 
calcium phosphate cements such as alpha-tricalcium 
phosphate (α-TCP) cement are constantly used by 
orthopedic and oral-maxillofacial surgeons because 
of their characteristics of biocompatibility and 
osteoconductivity. These cements are also considered 
to be biodegradable and bioactive materials, since they 
establish chemical bonds with the bone tissue, which 
facilitates proliferation of fibroblasts, osteoblasts and 
other bone cells(7).
From tissue engineering, it has been proposed that 
a complex of interactions involving osteoprogenitor 
cells, osteoinductive mediators and osteoconductive 
matrixes would be the ideal alternative for restoration 
of both soft and hard tissues(8). Knowing that inductive 
proteins such as growth factors regulate cell events 
that stimulate bone neoformation, combined applica-
tion of these with alpha-phosphate cement might be 
a promising strategy for stimulating osteogenesis in 
cases of difficult-to-repair bone damage. 
Platelet-rich plasma (PRP), which is characterized 
as a volume of plasma with a platelet concentration 
three to eight times greater than physiological 
levels(9-11), is an autologous source of growth factors 
and forms a therapeutic alternative for application 
together with bone substitutes such as α-TCP 
cement. According to Marx(12), PRP releases a set of 
seven trophic factors for which the carrier is blood 
coagulum. These factors include the three isoforms 
of platelet-derived growth factor (PDGF), alpha 
and beta transformation growth factors (TGF-α and 
TGF-β), vascular endothelial growth factor (VEGF) 
and epithelial growth factor (EGF).
The proteins released by the platelets create a mi-
croenvironment favorable towards tissue healing, in-
duction of chemotaxis, cell proliferation and differen-
tiation and tissue residue removal. PRP also contains 
proteins such as fibrin, fibronectin and vitronectin, 
which act as cell adhesion molecules, thus favoring 
osteoconduction, as well as being essential in forming 
bone matrix(13-15). Some investigators have used PRP 
in association with other biomaterials in an attempt to 
obtain better results in bone repairs than are achieved 
through PRP use alone(16-18).
Within this context, the aim of this study was to 
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compare the effect of PRP, as an autologous source of 
growth factors, on osteogenesis when applied sepa-
rately or in combination with granulated α-TCP ce-
ment, to cavity defects in rats.
MAtERIAL AND MEtHODs
Animals and experimentation groups
The present study was approved by the Ethics 
Committee for Animal Use (CEUA) of the Pontifical 
Catholic University of Rio Grande do Sul. Fourteen 
adult male Wistar rats (Rattus norvegicus) of approxi-
mate body weight 250 grams were used. Two of them 
were used as blood donors to obtain PRP. The remai-
ning 12 animals were used to conduct the experiment 
and were randomly distributed into two groups with 
different assessment periods (four and eight weeks). 
obtaining of platelet-rich plasma (PrP)
Two adult male rats were used as blood donors, after 
they had been anesthetized intraperitoneally using a solu-
tion formed by ketamine hydrochloride (50 mg/kg) and 
chlorpromazine hydrochloride (5 mg/kg) in the same sy-
ringe. Six milliliters of blood were drawn from the carotid 
artery of each animal and were immediately transferred 
to tubes containing a solution of acid citrate dextrose-A 
(ACD-A), in order to avoid coagulation.
The blood was subjected to two centrifugations (200g 
for 10 minutes and 400g for 10 minutes), in a hemato-
logical centrifuge (CELM – LS 3 Plus) in the Clinical 
Pathology Laboratory of Hospital São Lucas, PUCRS 
(HLS), in accordance with an adapted protocol(19). 
After the second centrifugation, platelet-poor plas-
ma (PPP) was obtained in the upper part of the tube, 
PRP in the intermediate zone and a small button of 
red blood cells at the bottom of the tube. The PPP was 
removed from the tube and discarded. The PRP was 
activated using a mixture of calcium chloride (CaCl2) 
and thrombin (600 IU/mL of thrombin in 1 mL of 5.9 
mg/mL CaCl2; Aventis Behring, São Paulo, Brazil) 
in the proportions of 1:2 of PRP. The PRP gel was 
applied either separately in the right cavity or mixed 
with granulated α-TCP cement in the left cavity of 
each animal, immediately after the bone lesions had 
been produced, in quantities of 100 µL.
Platelet counting
The numbers of platelets in the normal blood of the 
rats and in the PRP samples were quantified using an 
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automated cell counter (SYSMEX, model XT 1800, 
Roche®). This was done in the Clinical Pathology Labo-
ratory of Hospital São Lucas, PUCRS, in accordance 
with the manufacturer’s specifications.
Synthesis of granulated α-TCP cement
The granulated α-TCP cement used in this study 
was synthesized and supplied by the Biomaterials 
Laboratory (BIOMAT) of the Federal University of 
Rio Grande do Sul (UFRGS). Its composition was 
85% α-TCP and 15% semi-hydrated calcium sulfate. 
As recommended by the manufacturer(20), the cement 
was mixed with a liquid containing 2.5% Na2HPO4 
(accelerator) until reaching the desired consistency. 
The granule size was between 150 and 300 µm and 
the quantity applied to each animal was 50 mg.
Anesthetic and surgical procedures
The surgical procedures were performed at the 
Medical Skills and Surgical Research Laboratory of 
the School of Medicine of PUCRS. 
Anesthesia was administered in accordance with the 
protocol mentioned earlier. After the surgical access 
area on both femurs (right and left) had been shaved, 
the animals were positioned in lateral decubitus and an 
incision was made in the skin of the lateral face of the 
thigh, of length 1.5 cm. The vastus lateralis and biceps 
femoris muscles were divulsed and the femur was ex-
posed. In the anterolateral portion of the proximal di-
aphysis of the femur, a cavity defect was created using 
a Carbide drill bit, number 8, with a high-rotation mo-
tor, with constant irrigation using sterile physiological 
solution. The lesion was produced by the same surgeon 
in all the animals (5 mm x 2 mm), with sufficient depth 
to expose the medullary cavity of the femur(21), tak-
ing special care not to compromise the medial cortical 
bone, thereby diminishing the possibility of fracturing 
of the femur after the operation (Figure 1). The cavity 
in the right femur was filled with PRP alone, while 
the cavity in the left femur was filled with PRP plus 
granulated α-TCP cement.
Subsequently, the fascia lata was brought together 
using a Prolene 5-0 suture (Ethilon®, Johnson & John-
son, Brazil), and the skin was sutured using monony-
lon 4-0 thread (Ethilon®, Johnson & Johnson, Brazil). 
Postoperative period
The rats were kept in individual cages after the sur-
gery, in the same vivarium from which they origina-
ted. Analgesia was applied, consisting of ketoprofen, 
Figure 1 – Exposure of rats’ femurs for creation of cavity lesions of length 5 mm.
intraperitoneally at a dose of 5 mg/kg. The animals 
were monitored during the immediate postoperative 
period by a surgical team.
radiographic analyses
On the day before sacrificing the animals (either four 
or eight weeks after the operation), radiographs on all 
the femurs were produced. To obtain the images, the 
animals were anesthetized and positioned in ventral de-
cubitus, with the aid of the Mamomat 3000 mammogra-
phy apparatus (Siemens®). Specific image transducers 
for mammography (Image Plate, Fuji®) were used.
The radiographic technique consisted of a Mo-Mo 
target-trail combination, tube accelerator tension of 28 
kVp and load of 14 mAs. The technique was adjusted 
so as to view the critical lesions in the rats’ femurs. 
The digitized radiographic images were evaluated by 
a properly capacitated experienced examiner, with 
the aid of the Image J software. To ensure and test 
the reproducibility of the image analysis process, a 
standard operational procedure was developed and the 
intraclass correlation coefficient was applied to two 
groups: one group without experience of this type of 
analysis, and no familiarity with the Image J software 
or with the characteristics of the lesions; and another 
group consisting of capacitated and experienced indi-
viduals. The coefficient values taken as the reference 
were: ICC < 0.4 (poor); 0.4 ≤ ICC < 0.75 (satisfac-
tory); and ICC ≥ 0.75 (excellent).
At the time of evaluating each lesion, the area of 
the lesion was determined (mm²) and the mean pixel 
values and their respective standard deviations. The 
value “0” (zero) represented absence of the lesion, ob-
served by means of the parameters described above. 
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Histological preparation
After four or eight weeks, the experimental ani-
mals were anesthetized using the same protocol as 
used for the surgical procedures, and were sacri-
ficed using a lethal dose of 100 mg/kg thiopental. A 
surgical approach was used to remove the right and 
left femurs. The bone was sectioned with the aid 
of a drill with a Carbide no. 8 bit, while preserving 
the lesion site with margins of 1 mm at each end 
of the defect.
The samples were fixed in 10% buffered formalin, 
dehydrated in a series of alcohol solutions of increasing 
grade, clarified using xylol and decalcified using a 
50% formic acid solution. The slides were produced 
in the Pathology Laboratory of Hospital São Lucas, 
PUCRS. After complete decalcification, the femurs 
were embedded in paraffin and sections of thickness 
5 µm were cut using a microtome. 
To evaluate the bone neoformation, picrosirius 
staining was used. This acts through precipitation of 
molecules of the stain Sirius red, which is deposited 
in parallel with the collagen molecules, thus causing 
an increase in the birefringence of the fibers that have 
conserved collagen, when observed under polarized 
light, thereby showing the areas of bone matrix. 
After keeping the slides in a heated chamber 
at 60ºC for 24h, they were deparaffinized and hy-
drated in running water. Subsequently, they were 
incubated in a picrosirius solution of concentration 
1% for one hour, followed by washing in running 
water for 20 minutes. 
The slides were coded in such a way that the 
examiner did not know which treatments they be-
longed to. Subsequently, the slides were photo-
graphed for analysis.
image analysis - histomorphometry
The slides were read by the same examiner, under 
a Zeiss Axioskop 40 optical microscope with a 5x 
objective lens. To capture the images, a CoolSNAP™ 
Pro cf camera was used (Media Cybernetics, Inc.), 
coupled to the microscope and to a computer, thereby 
producing a magnification similar to a 10x objective 
lens. Through this, the resultant images came to have 
a magnification of 50x. Each image was captured un-
der normal light and polarized light, for subsequent 
differentiation and quantification of the area with the 
presence of collagen. 
Two fields per slide were selected to represent the 
entire lesion area. Also, on the same slide, for each 
area with the lesion, a region adjacent to the defect, 
with similar dimensions, was selected to represent the 
normal bone (ideal: 100% bone neoformation). 
After registering the images, they were analyzed 
using the Image ProPlus® software, version 4.5.1 
(Media Cybernetics, Inc.). This made it possible, by 
means of counting the numbers of pixels, to measure 
the area in micrometers corresponding to each defect 
and to the normal bone. To differentiate the collagen, 
a measurement of the ratio of birefringent tissue per 
tissue unit was obtained (pixel/µm), using the images 
captured in normal light and in polarized light.
The area in micrometers was transformed into 
percentage neoformation by means of comparison 
between the area of bone tissue in the lesion and the 
area of normal bone tissue in the adjacent region, and 
this was stipulated as 100% neoformation (ideal)(22,23).
stAtIstICAL ANALysIs
The data were expressed as means and standard 
deviations for variables with normal distribution. To 
compare values relating to the area (mm²), longitu-
dinal length (mm) are area of neoformation (%) of 
the lesion, analysis of variance (ANOVA) was used, 
followed by Tukey’s post-hoc test. The significance 
level was set at α = 0.05.
REsULts
Clinical results
The anesthetic protocol used was shown to be 
effective for carrying out the surgical procedures. The 
medications administered after the operation were 
sufficient to maintain the animals’ wellbeing, and no 
difficulty in moving the operated limbs was observed. 
The surgical wounds healed adequately and none of 
the rats presented any signs of infection or clinical 
complications during the study. 
Platelet count
The number of platelets in the normal blood, 
before centrifugation to obtain PRP, was 459,000 
platelets/µL, while it was 3,181,000 platelets/µL in 
PRP. The quantity of leukocytes was also higher 
in PRP than in normal blood (2,800 leukocytes/
µL). The concentration of red blood cells found 
in PRP was 730 cells/µL, and in normal blood,
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7,420 cells/µL. The high concentrations of platelets 
and leukocytes and the low concentration of red 
blood cells confirmed that the technique used to 
obtain PRP was effective.
radiographic and histological results 
In the process of validation of the radiographic 
image analyses, the variations in length and area 
measurements made by the two experienced 
evaluators were less than the dimensions of one 
pixel, with ICC = 0.8, which demonstrated that 
the process presented high reproducibility between 
properly capacitated individuals. 
Numerically, the PRP treatment presented lower 
performance than shown by the treatment with α-TCP 
plus PRP. The mean area measurements of the two 
groups and their respective standard deviations are 
presented in Figure 2.
The radiographic images analyzed (Figure 3) 
demonstrated differences in bone constitution between 
the two treatments. After eight weeks, the mean for 
the lesion area in the PRP group was 3.23 mm² ± 
1.46, while in the α-TCP + PRP group, it was 1.91 
mm² ± 0.93. However, this difference did not present 
significance (p = 0.388).
In observations on the slides using an optical mi-
croscope, no signs of inflammation or necrosis were 
seen on the bone or adjacent tissues. In all the cases, 
bone tissue neoformation was observed in all areas 
of the surgical defect, both at the margins and in the 
central region. 
After four week, it was observed that disorganized 
connective tissue had formed, permeating the areas 
of bone neoformation that filled the surgical cavities. 
After eight weeks, it was seen that the dimensions 
of the lesion had decreased, with a small area of 
organized connective tissue permeating the areas of 
bone neoformation that filled the surgical cavities, 
thus suggesting that the bone structure was undergoing 
remodeling. Under polarized light, the presence of 
organized collagen fibers could be seen (Figure 4).
In Table 1, the evolution of the bone healing in the 
PRP group can be seen through the means for bone neo-
formation. The difference between the means obtained 
after four and eight weeks in the group with PRP alone 
was significant (p = 0.015), and this demonstrates that 
after four weeks, the area of bone neoformation was 
still immature, in contrast with the group with α-TCP 
plus PRP (Figure 4).
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Figure 2 – Mean areas of the lesion and respective standard deviations, after four 
and eight weeks.
Figure 3 – Radiographic images representing the neoformed bone in the area of 
the lesion in the PRP group (right) and α-TCP + PRP group (left), after eight weeks. 
Note that a better repair was achieved in the femur treated with α-TCP + PRP.
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Figure 4 – PRP group (A and B) and α-TCP + PRP group (C and D), four weeks 
after the operation. Picrosirius red staining under normal light (upper images, A and 
C) and under polarized light (lower images, B and D), showing that collagen was 
more abundant in the α-TCP + PRP group, represented by the more lightly stained 
regions. Magnification 50x.
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Comparing the mean areas of bone neoformation 
independently of the time period, it was observed that 
the difference between the two treatments tended to 
be similar (p = 0.779). The means for neoformation 
and the respective standard deviations can be viewed 
in the graph of Figure 5.
and stimulate tissue restoration. It is believed that 
interactions between these parameters promote bone 
regeneration(8,28,29).
To provide support for cell growth and osteogenic 
differentiation, use of scaffolds produced from different 
biomaterials is important. In the same way, growth 
factors are capable of improving the osteogenic potential 
of scaffolds such as TCP, when applied in conjunction. 
Some studies have affirmed that α-TCP cement 
not only is biocompatible but also is bioconductive 
and bioactive(20,25,30,31). There is evidence that the 
growth factors obtained from  PRP may regulate the 
reconstruction and physiological bone remodeling, and 
are a powerful form of treatment in lesion repair(10,18,32-35). 
In the light of these precepts, combined application of 
α-TCP cement and PRP seems to fit the ideal properties 
characterizing these interactions.
In the present study, the platelet concentration in 
the PRP from the rats was seven times greater than the 
level in normal blood (PRP = 3,181,000 platelets/µL). 
The therapeutic concentration of platelets in PRP that is 
considered ideal in humans is approximately 1,000,000/
µL(15). Trowbridge et al(36) affirmed that the mean quantity 
of platelets in rats is significantly higher than in humans, 
while the mean volume of platelets is significantly lower 
than in humans. Thus, there are biological differences 
between species that need to be taken into consideration. 
Only the protocols for obtaining human PRP are 
standardized, along with the ideal platelet concentrations 
and growth factor levels. Thus, the therapeutic levels 
of platelet concentrations and growth factor levels in 
animals still need to be defined.
In the radiographic analysis presented here, it was 
observed that the performance of the group treated 
with PRP alone was numerically lower. However, 
the difference found between the treatments was not 
significant at either of the times analyzed (Figure 2). 
The treatment with α-TCP plus PRP presented smaller 
mean lesion areas after four and eight weeks, which 
indicates better bone repair.
The results obtained demonstrated that PRP 
stimulates bone remodeling, in a similar manner to 
results found in the literature, in which PRP was applied 
to the same species(37). All the defects in both groups 
evaluated (PRP alone and α-TCP + PRP) presented 
remodeled bone after eight weeks. The histological 
data suggest that application of α-TCP cement and 
PRP together may produce an early osteogenic effect, 
table 1 – Differences in mean areas of the lesion and the bone 
neoformation found after four and eight weeks.
treatment
Diference between four and eight weeks
Area (mm²) p Neoformation (%) p
PRP 2,36 0,089 16 0,015
TCP+PRP 0,74 0,447 13 0,067
Statistically significant difference for p ≤ 0.05.
100
80
60
40
20
0
4 weeks                                 8 weeks
PRP α - TCP + PRP
Figure 5 – Mean areas of bone neoformation and respective standard deviations, 
after four and eight weeks.
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DIsCUssION
The most effective treatment, which is today 
considered to be the gold standard for repairing 
bone tissue damage for which recovery is difficult, 
is autologous grafting. Nonetheless, despite its 
advantages, among which histocompatibility and 
high osteoinductive and osteoconductive capacity 
can be highlighted, autologous grafts present some 
inconvenient features. Among their limitations are the 
limited quantity of donor tissue, the failure created in 
the graft extraction region and the difficulty in gaining 
acceptance from patients(24-27).
A variety of biomaterials are constantly being 
investigated as bone tissue replacements, with the aim 
of finding an alternative that presents the same benefits 
as autologous grafts, but free from its disadvantages. 
The bone repair process involves a series of cell 
elements, chemical mediators and osteoconductive 
matrixes that regulate events at the molecular level 
511
given that after four weeks, the mean for the latter was 
73.3% ± 12.7, i.e. greater than for the PRP group. After 
eight weeks, the mean for the combined application 
was 86.7% ± 9.8, i.e. 13 percentage points greater than 
after four weeks, but this difference was not significant 
(Table 1). Studies have proven that combining PRP 
with biomaterials optimizes and accelerates the bone 
tissue regeneration process(38).
The histological analyses also demonstrated that 
there was no inflammatory response or necrosis in 
any of the animals, and this is concordant with studies 
that aimed to assess the biocompatibility of α-TCP 
cement(39,40). Another possible explanation for the 
absence of inflammation or bone necrosis is that saline 
solution was used to constantly irrigate the surgical 
field while the defects were being created, and that 
both the cement and the surgical materials used in all 
the procedures had been sterilized.
According to Marx et al(10), PRP has an influence on 
cells. Therefore, when used in combination with syn-
thetic bone substitutes, a synergic effect on bone neo-
formation should be presented. However, the benefits 
from PRP depend on the quantity of osteoprogenitor 
cells present at the implantation site and on the action 
of the growth factors released by the platelets(41).
In the histomorphometric analysis, bone growth 
around the particles of α-TCP cement was observed, 
along with the presence of collagen. The bioactivity 
and osteoconductivity of the α-TCP granules may 
favor bone regeneration. It is known that partial 
degradation of calcium phosphate cements causes 
release of calcium and phosphate ions into the bone 
microenvironment, which over the long term promotes 
mineralization and increases bone neoformation(42). 
Kihara et al(43) observed bone neoformation on 
the surface and interior of α-TCP particles when 
this cement was applied to bone defects in rabbits, 
similarly to the present study. These data provide 
support for the affirmation that α-TCP cement is an 
osteoconductive material, thus enabling bone matrix 
development from this.
For bone substitutes to become properly integrated 
with the bone tissue, it is important that their shape 
should be preserved. In carrying out the present study, 
some difficulty was found in handling α-TCP cement 
in relation to its solubility, which impairs its adhe-
sion to the surgical site because of the presence of 
large quantities of fluid structures (blood and bone 
marrow). However, this limitation was controlled by 
means of adequate aspiration and a dry surgical field, 
in order to avoid displacement and extravasation of 
the cement after it was applied.
CONCLUsION
The results from this study suggest that treatment 
with α-TCP cement combined with PRP did not 
present any statistically significant different in relation 
to use of PRP alone. With regard to the effect of the 
two treatments on osteogenesis in cavity defects in 
rats’ femurs, the data indicated that there may be any 
early effect when PRP and α-TCP cement are applied 
together, such that the osteoinductive activity may 
be boosted.
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